文献速递性腺与生殖内分泌肥胖与代谢综合征糖尿病

西班牙裔/拉丁裔社区健康研究中多囊卵巢综合征、代谢综合征与炎症的关系

Polycystic Ovary Syndrome, Metabolic Syndrome, and Inflammation in the Hispanic Community Health Study/Study of Latinos.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

在西班牙裔社区健康研究/拉丁裔研究(HCHS/SOL)的7316名23-82岁女性中,多囊卵巢综合征(PCOS)患病率为18.8%,PCOS与代谢综合征(MetS)患病率显著相关(OR=1.41,95%CI 1.13-1.76),并与空腹血糖受损(IFG)和甘油三酯升高(TGL)相关。绝经状态和C反应蛋白(CRP)对PCOS-MetS关联存在效应修饰。

要点

  • PCOS患病率为18.8%,与MetS患病率显著相关(OR=1.41,95%CI 1.13-1.76)。
  • PCOS与IFG(OR=1.42,95%CI 1.18-1.72)和TGL升高(OR=1.48,95%CI 1.20-1.83)显著相关。
  • 绝经前状态或CRP升高时PCOS与MetS的关联更强,交互作用P值分别为0.02和0.04。

核心结论

  • 西班牙裔/拉丁裔PCOS女性较无PCOS同龄女性有更高的MetS、IFG和TGL升高 odds。
  • 交互分析显示,绝经前或高炎症状态的PCOS女性MetS odds更高。
  • 作者认为针对西班牙裔/拉丁裔女性的干预应聚焦这些结局以有效管理疾病。

研究设计与样本

  • HCHS/SOL为多中心、纵向、观察性研究,纳入美国西班牙裔/拉丁裔人群。
  • 本分析为横断面分析,样本为 Visit 2 中自报PCOS和MetS的23-82岁女性,共7316名。

主要发现

  • PCOS患病率为18.8%。
  • PCOS与MetS患病率显著相关:OR=1.41(95%CI 1.13-1.76)。
  • PCOS与IFG相关:OR=1.42(95%CI 1.18-1.72);与TGL升高相关:OR=1.48(95%CI 1.20-1.83)。
  • 绝经状态对PCOS-MetS关联存在效应修饰:绝经前OR=1.46(Pint=0.02),绝经后OR=1.34(Pint=0.06)。
  • CRP对PCOS-MetS关联存在效应修饰:CRP升高组OR=1.41(Pint=0.04),CRP正常组OR=1.26(Pint=0.16);调整CRP后PCOS对MetS的效应减弱为OR=1.29(95%CI 0.93-1.78)。

临床怎么用

  • 作者认为针对西班牙裔/拉丁裔女性的干预应聚焦MetS、IFG和TGL升高这些结局,以有效管理疾病。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Polycystic ovary syndrome (PCOS) is a multifaceted endocrine disorder with reproductive and metabolic dysregulation. PCOS has been associated with inflammation and metabolic syndrome (MetS); however, the moderating effects of inflammation as measured by C-reactive protein (CRP) and menopause on the PCOS-MetS association have not been studied in Hispanic/Latinas with PCOS who have a higher metabolic burden. OBJECTIVE: We studied the cross-sectional association between PCOS and (1) MetS in 7316 females of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), (2) subcomponents of MetS including impaired fasting glucose (IFG) and elevated triglycerides (TGL), and (3) effect modification by menopausal status and CRP. DESIGN: The HCHS/SOL is a multicenter, longitudinal, and observational study of US Hispanic/Latinos. Our study sample included females from visit 2 with self-reported PCOS and MetS (ages 23-82 years). RESULTS: PCOS (prevalence = 18.8%) was significantly associated with MetS prevalence [odds ratio [odds ratio (OR) = 1.41 (95% confidence interval: 1.13-1.76)], IFG and TGL (OR = 1.42 (1.18-1.72), OR = 1.48 (1.20-1.83), respectively]. We observed effect modification by menopausal status (ORpre = 1.46, Pint= .02; ORpost = 1.34, Pint= .06) and CRP (ORelevated = 1.41, Pint= .04; ORnormal = 1.26, Pint= .16) on the PCOS-MetS association. We also observed a superadditive interaction between CRP and PCOS, adjusting for which resulted in an attenuated effect of PCOS on MetS (OR = 1.29 [0.93-1.78]). CONCLUSION: Hispanic/Latino females with PCOS had higher odds of MetS, IFG, and elevated TGL than their peers without PCOS. Interaction analyses revealed that the odds of MetS are higher among PCOS females who have premenopausal status or high inflammation. Interventions in Hispanic/Latinas should target these outcomes for effective management of the disease.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Rao HC, Meyer ML, Kominiarek MA, et al. Polycystic Ovary Syndrome, Metabolic Syndrome, and Inflammation in the Hispanic Community Health Study/Study of Latinos. J Clin Endocrinol Metab. 2025. PMID: 38888178. doi:10.1210/clinem/dgae426

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。